No CrossRef data available.
Article contents
Setting Research Priorities: Human Germ-Line Gene Therapy in Perspective
Published online by Cambridge University Press: 17 May 2016
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0730938400018402/resource/name/firstPage-S0730938400018402a.jpg)
- Type
- Symposium: Regulating Germ-Line Gene Therapy
- Information
- Copyright
- Copyright © Association for Politics and the Life Sciences
References
Blank, R.H. (1992). “The Limits of Technology Assessment: Values, Time Frame and Public Expectations.” In Bryner, G.(ed.), Science, Technology, and Politics: Policy Analysis in Congress. Boulder, CO: Westview.Google Scholar
Bonnicksen, A.L. (1994). “National and International Approaches to Human Germ-Line Gene Therapy.” Politics and the Life Sciences 13:39–49.Google Scholar
Mathieu, D. (1993). “Ending the Experiment: Dilemmas of the Experimental/Therapeutic Distinction.” In Blank, R.H. and Bonnicksen, A.L.(eds.), Emerging Issues in Biomedical Policy, Volume 2. New York: Columbia University Press.Google Scholar